Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
German Center for Lung Research · Baylor College of Medicine · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
58
total citations
- FWCI
- 65.91
- Percentile
- 100%
- References
- 29
Citations per year
Authors
16Topics & keywords
Topics
Keywords
- Medicine
- Placebo
- Dupilumab
- Pulmonary disease
- Internal medicine
- Double blind
- Inflammation
- Randomized controlled trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.